51384618 Suxibuzone

Definition

UNSPSC 51384618

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C24H26N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86TDZ5WP2B, chemically known as 3,5-pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) but generally known as suxibuzone, which bears US NIH Compound Identifier 5362. European Medicines Agency schedules Suxibuzone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10789MIG. The term SUXIBUZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules suxibuzone in its Anatomical Therapeutic Chemical (ATC) Classification. SUXIBUZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule suxibuzone under HS 29331990 and SITC 51571. As of Q4 2014, SUXIBUZONE remains the US FDA Preferred Term for this commodity. Suxibuzone bears US NLM identifiers UMLS ID C0075667 and NCI Concept Code C73095. SMILES: O(CC1(CCCC)C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1)C(=O)CCC(=O)O.

Same parent

Under 51384600 · 33

51384601 Dipyrone or metamizol or metamizole Commodity 51384602 Aminophenazone or aminopyrine Commodity 51384603 Antipyrine or phenazone or phenazon or analgesine Commodity 51384604 Bendazac or bendazolic acid Commodity 51384605 Benzydamine Commodity 51384606 Bisfenazone Commodity 51384607 Celecoxib Commodity 51384608 Difenamizole Commodity 51384609 Oxyphenbutazone Commodity 51384610 Edaravone or norphenazone Commodity 51384611 Feprazone Commodity 51384612 Kebuzone or ketophenylbutazone Commodity 51384613 Lonazolac Commodity 51384614 Mofebutazone Commodity 51384615 Niprofazone Commodity 51384616 Pirazolac Commodity 51384617 Propyphenazone Commodity 51384618 Suxibuzone You are here 51384619 Trifezolac Commodity 51384620 Phenylbutazone Commodity 51384621 Aminophenazone cyclamate Commodity 51384622 Praxadine Commodity 51384623 Bendazac lysine dihydrate Commodity 51384624 Bendazac sodium Commodity 51384625 Benzydamine hydrochloride Commodity 51384626 Lonazolac calcium Commodity 51384627 Metamizole sodium Commodity 51384628 Mofebutazone sodium Commodity 51384629 Oxyphenbutazone anhydrous Commodity 51384630 Oxyphenbutazone piperazine Commodity 51384631 Phenazone salicylate Commodity 51384632 Phenylbutazone calcium Commodity 51384633 Phenylbutazone sodium Commodity

Activities that produce or sell this

KBLI · 9

Inherited from family 51380000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47111 Perdagangan Eceran Berbagai Macam Barang yang Utamanya Makanan, Minuman, atau Tembakau dengan Sistem Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class